Metabolites as Risk Factors for Diabetic Retinopathy in Patients with Type 2 Diabetes: a 12-year Follow-up Study.
Lilian Fernandes SilvaJenna HokkanenJagadish VangipurapuAnniina OravilahtiMarkku LaaksoPublished in: The Journal of clinical endocrinology and metabolism (2023)
Our study is the first large population-based longitudinal study to identify metabolites for DR. We found multiple metabolites associated with an increased and decreased risk for DR from several different metabolic pathways.